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ABSTRACT Three highly conserved active site residues (Ser, Tyr, and Lys) of the family of short-chain alcohol dehydrogenases/
reductases (SDRs) were demonstrated to be essential for catalytic activity and have been denoted the catalytic triad of SDRs. In
this study computational methods were adopted to study the ionization properties of these amino acids in SDRs from Drosophila
melanogaster and Drosophila lebanonensis. Three enzyme models, with different ionization scenarios of the catalytic triad that
might be possible when inhibitors bind to the enzyme cofactor complex, were constructed. The binding of the two alcohol
competitive inhibitors were studied using automatic docking by the Internal Coordinate Mechanics program, molecular dynamic
(MD) simulationswith theAMBERprogrampackage, calculation of the free energy of ligand binding by the linear interaction energy
method, and the hydropathic interactions force ﬁeld. The calculations indicated that deprotonated Tyr acts as a strong base in the
binary enzyme-NAD1 complex. Molecular dynamic simulations for 5 ns conﬁrmed that deprotonated Tyr is essential for anchoring
and orientating the inhibitors at the active site, which might be a general trend for the family of SDRs. The ﬁndings here have
implications for the development of therapeutically important SDR inhibitors.
INTRODUCTION
The enzymes involved in catalyzing oxidation of alcohols and
reduction of aldehydes/ketones by using nicotinamide ade-
nine dinucleotide phosphate (NAD(P)(H)) as a coenzyme are
termed alcohol dehydrogenase (ADH; Enzyme Commission
number (EC) 1.1.1.1). These enzymes are found in almost all
organisms; and despite their similar functions, they differ in
primary as well as three-dimensional (3D) structures. Hence,
they are classified into different enzyme families such as the
short-chain dehydrogenase/reductase (SDR) and medium-
chain dehydrogenase/reductase superfamilies (1–3). The SDR
family constitutes a functionally heterogeneous group of
enzymes with .3000 primary sequences spanning several
EC classes (1,4–6). The pairwise sequence identities within
the SDR family is quite low (10%–30%), whereas their 3D
structures show a highly similar a/b folding pattern (1,6).
As SDRs are expected to be involved in a variety of human
diseases, they are potential therapeutic targets (6).
The ADHs in Drosophila (DADH) belong to the SDR
family, whose physiological functions involve metabolism
and detoxification of alcohols, with ethanol as an energy
source (7,8). Nearly 60 DADHs from different Drosophila
species are known and biochemically characterized (9).
Some DADHs have been studied structurally (10–12) (Fig.
1) and by enzyme kinetics to elucidate their structure-
function relationships (13–15). DADHs consist of two
identical subunits of ;27,000 Da each (;255 amino acids)
(16,17), where each subunit folds into a central seven- or
eight-stranded b-sheet, flanked on each side by three
a-helices and a loop region that forms the active site (10,11).
DADHs convert short- and medium-chain primary and
secondary alcohols to their corresponding aldehydes/ketones
(15), using NAD1 as coenzyme (Eq. 1). In addition, the
DADHs oxidize aldehydes to their corresponding carboxylic






Secondary alcohols were found to be better substrates than
primary alcohols; and R() secondary alcohols are better
substrates than S(1) secondary alcohols (15). Enzyme kinetic
studies indicate a compulsory ordered pathway (Scheme 1)
where the coenzyme binds before the substrate (15,21). Site-
directed mutagenesis and structural studies suggest that
one amino acid between b-strand E and a-helix F (Ser-138)
and two amino acids in a-helix F (Tyr-151 and Lys-155)
(Drosophila lebanonensis numbering) at the active site are
involved in the catalytic reaction (1,22,23) (Fig. 1). These
amino acids are denoted the catalytic triad of SDRs (10,11,
22–24) and represent the most characteristic feature of the
entire family (1,25,26). Tyr-151 is strictly conserved, whereas
Ser-138 and Lys-155 are conserved in most of the SDRs (1).
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Experimental studies of DADHs showed that a proton at
the active site is released upon formation of the binary
ENAD1 complex (Fig. 2), whereas protons are not released
upon formation of the ternary complexes or the binary
ENADH complex (27–30). The release of proton from the
binary ENAD1 complex is essential for alcohol binding
and catalysis as well as for binding alcohol competitive
inhibitors. The amino acid responsible for the proton
release is not known. pH dependence of ligand binding
indicated that Tyr-151 or Lys-155 could be responsible for the
proton release (30). However, comparison of the reaction
mechanism of DADHs with that of horse liver ADH in-
dicated that the proton release produced a negative charge
at the active site. This negative charge acts as a strong base
or nucleophile for extracting a proton from the bound
alcohol. The most plausible candidate for the proton release
was Tyr-151 (28). Later, x-ray crystallographic studies
showed that the OH group of the substrates in the ternary
complexes is located between Tyr-151 and Ser-138 (11,12,
22,24). In these structures, the Tyr-OH group is positioned in
a hydrogen-bonding distance to the O29 atom of the NAD-
ribosyl moiety, and Lys-155 is positioned close to both the
O29 and O39 atoms of NAD-ribosyl moiety. Site-directed
mutagenesis studies of Tyr-151, Lys-155, and Ser-138 in
DADH and other SDRs indicated that all three residues were
important for enzyme activity (31,32). A kinetic study of
DADH showed that the pKa ionization enthalpy of the proton-
releasing residue was unusually high, suggesting that Ser-138
rather than Tyr-151 is the catalytic residue (29). In such a sce-
nario, the pKa value of Tyr-151 is already down perturbated
(,6) in the binary ENAD1 complex, and hence not detected
during the enzyme kinetic studies. Kinetic studies of two
other SDR enzymes suggest that the conserved Tyr acts as
the strong base (33,34). A recent study on SDR enzymes re-
veals a possible water channel in the interior of the enzyme
that connects the protein surface with the active site through
Lys-155, and hence this channel could be involved in a
proton relay system (35). Theoretical calculations of possi-
ble ionizable groups in the DADH binary complex result in a
pH curve that is almost identical to the experimental curve. In
the theoretical curve, the ionization of Tyr-151 and Lys-155 is
shown to be coupled (36). The pH dependence of the proton
abstraction correlates with the reorganization of the hydrogen-
bonding network at the active site, where the O29 group of the
NAD1-ribose plays a central role by coupling the Tyr-OH
group with the side-chain nitrogen in Lys-155 and the water
channel.
We used molecular modeling of two SDR enzymes to in-
crease the understanding of the role of the triad in the cat-
alytic process. The enzyme models of D. lebanonensis ADH
(DlADH) and Drosophila melanogaster ADH (DmADH)
were created with different ionization scenarios of the triad
that might be possible upon inhibitor binding. As the cat-
alytic triad is highly conserved among the SDRs, knowledge
about the ionization of this triad of DlADH and DmADH
may help to develop inhibitors of human SDRs. Based on
FIGURE 1 Ribbon representation of the dimer associa-
tion of DlADH (PDB ID: 1SBY). Secondary structure
nomenclature is as suggested in the publication of the x-ray
structure (10) and is shown for one of the subunits. Amino
acids lining the R1 and R2 pockets of the active site are
shown by the green and blue stick models, respectively.
The color coding of secondary structures is red for
a-helices, aquamarine for b-strands, magenta for 3–10
helices (g), and blue for loops. The designation of the
active site pockets was followed from the description of
crystallographic studies by Benach (11).
SCHEME 1 Compulsory ordered ternary complex mechanism describ-
ing the kinetics of DADH catalysis. O is NAD1, R is NADH, S is alcohol,
and P is aldehyde/ketone. The constants (k and k9) are individual kinetic
constants.
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their experimental dissociation constants (Kd) with DlADH
(27) and DmADH (30) (Table 1), two alcohol competitive
inhibitors, pyrazole (PYR) and 2,2,2-trifluoroethanol (TFE)
(Fig. 3), were automatically docked by the Internal Coor-
dinate Mechanics (ICM) program, version 3.0.28 (37), to
the active site of DlADH (Protein Data Bank (PDB) ID:
1SBY) and DmADH (PDB ID: 1MG5). The complexes
were studied by molecular dynamic (MD) simulations by
the AMBER 7.0 (38) suite of programs, and the free energies
of inhibitor binding were calculated with linear interaction
energy (LIE) (39–41) and Hydropathic INTeractions (HINT)
(42) methods.
MATERIALS AND METHODS
The structures of DlADH and DmADH consist of two identical subunits.
The docking by ICM was performed in both subunits, whereas 750 ps MD
and subsequent LIE calculations were performed for one subunit only.
However, for one of the putative ionization scenarios, 5 ns MD followed by
LIE analyses were performed for both the subunits of the DADHs.
ICM docking and binding energy calculations
Preparation of enzyme and ligand models
The x-ray crystallographic structure of the ternary complexes—DlADH
NAD1TFE (PDB ID: 1SBY) and DmADHNADHacetate (PDB ID:
1MG5)—were loaded into the ICM program, with subsequent deletion of
the cofactors and ligand molecules. NAD1 was inserted into the DmADH
model by superimposing the PDB files 1SBY and 1MG5. The default macro
of ICM was used for adding and optimizing the hydrogen atoms, assigning
ECEPP/3 (43) partial charges, and subsequent local minimizations for re-
lieving bad contacts. The minimization was carried out in the presence of
restraints so that the enzyme conformations remained close to the x-ray
crystallographic coordinates. Upon release of a proton, a negative charge at
the active site is formed to facilitate ligand binding to the ENAD1 complex.
So, enzymemodels with three different charge scenarios of the catalytic triad
that may explain the experimental observations were constructed for the
DADHs. A fourth scenario was also constructed with the entire catalytic
triad protonated. Such a scenario should not allow ligand binding to the
ENAD1 complex but was included as a test of the docking procedure.
Enzyme models with the following charge scenarios were constructed
(DlADH numbering):
A. Ser-138 and Tyr-151 deprotonated and Lys-155 protonated (Ser-O=
Tyr-O=Lys-NH13 )
B. Ser-138 protonated and Tyr-151 and Lys-155 deprotonated (Ser-OH/
Tyr-O/Lys-NH2)
C. Ser-138 and Lys-155 protonated and Tyr-151 deprotonated (Ser-OH=
Tyr-O=Lys-NH13 )
D. Ser-138, Tyr-151, and Lys-155 protonated (Ser-OH=Tyr-OH=Lys-
NH13 )
The possibility of a coupled ionization between Tyr-151 and Lys-155 as
previously suggested by theoretical calculations (36) corresponds to scenario
(C). The coordinates of TFE were extracted from PDB ID 1SBY, whereas
the structure of PYR was constructed by ICM, as an experimental structure
for PYR is not available. The ICM program was used to assign atomic point
charges to the inhibitors and to optimize the potential energy using the
MMFF94 force field (44).
TABLE 1 Experimental inhibition constants (KEO,I) obtained from kinetic studies
DmADH (30) DlADH (27,66)
PYR TFE PYR TFE
pH KEO,I (mM) KEO,I (mM) pH KEO,I (mM) KEO,I (mM)
10 4.5 (7.26) 1.1 (4.01) 10 12 (6.69)
9.5 4.3 (7.29) 1.1 (4.01) 9.5 14 (6.58) 2.5 (3.53)
8.5 4.5 (7.26) 1.1 (4.01) 9 12 (6.69)
7.5 8.8 (6.86) 2.1 (3.63) 8 15 (6.55)
6.6 26 (6.23) 7.3 (2.9) 7 22 (6.32)
5.9 37 (6.02) 9.3 (2.7) 6 63 (5.71)
E ¼ enzyme, O ¼ NAD1, and I ¼ inhibitor. The values in parentheses are the corresponding free energy of binding (kcal/mol) calculated by DG ¼ RTlnKi.
FIGURE 2 Mechanism proposed for DADH catalysis. E
represents the enzyme, and BH represents an ionizing
group with a pKa value of 7.1 and 7.3 in DlADH at 23.5C
and 19.0C, respectively (27,71), and 7.6 in DmADHS
(slow alleloenzyme) at 23.5C (28,30). The insert shows
the variation of F2 with varying pH for DlADH at 19.0C,
where F2 ¼ (1/k2)(1 1 (k2/k)(1 1 (k9/k92))) and the
kinetic constants are those in Scheme 1. It was shown that
only k2, i.e., the kon velocity for the alcohol, varied with
pH, and hence F2 ¼ F*2 (1 1 ([H1]/Ka)). The theoretical
curve is based on a pKa of 7.3 and a F*2 of 2.0 mMs.
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Docking and scoring protocol
Flexible ligand docking was performed with the default script in ICM for
rigid targets with grid potentials into both DmADH and DlADH. Grid maps
with grid spacing of 0.5 A˚ were created manually. The grid maps included
the amino acids suggested by the x-ray crystallography complexes as part of
the binding site. During the docking process, the ligand position and the
conformations were changed randomly with pseudo-Brownian movements
of the entire ligand or by rotation of torsion angles followed by a double-
energy Monte Carlo (MC) minimization scheme as previously described
(37). This procedure included an analytical gradient minimization in the
ECEPP/3 force field (43) and an optimization in the MMFF94 force field
(44). The metropolis (45) rule was applied to accept or reject the new
conformations. Both the length of the docking run and the local minimi-
zation were determined automatically, depending on the size and number of
the torsion angles of the ligand. A stack of 20 geometrically different target-
ligand complexes were accumulated based on their ICM pose scoring. The
energy terms used in the process were as follows:
E ¼ Eint1Evdw1Ehb1Ehp1Eel; (3)
where Eint is the internal energy of the ligand calculated by the ECEPP/3
force field; and Evdw, Ehb, Ehp, and Eel are the van der Waals forces (vdW),
hydrogen bonding, hydrophobic, and electrostatic interactions, respectively,
between the target and the ligand. Grid points were assigned on the rigid
conformation of the enzyme. On every grid point, the interaction energies
were precalculated for efficiency.
Out of the stack of 20 complexes, only ‘‘true’’ poses were considered for
further analyses. A pose was defined ‘‘true’’ if TFE was oriented in a
binding mode similar to that observed in the 1SBY complex. For PYR, a
pose was defined as ‘‘true’’ when 1), the carbon atom with a double bond to
the nitrogen atom was oriented into the R1 binding pocket; 2), the N1-H
bond was positioned in the region of the catalytic amino acids Ser-138 and
Tyr-151; and 3), the N2 was positioned close to the C4 position of nicotine
amide ring. Thus, the accepted complexes were further evaluated by
calculating the binding energies by ICM.
Calculation of binding energies by ICM
Free energies of binding were calculated using the rapid exact boundary
element solution (46–48) of the Poisson equation to evaluate the electrostatic
contribution to the interactions. This method globally optimizes the surface
side-chain orientations to derive the binding energies from a realistic model
of the solvated states of the molecules (49). The energy scheme for parti-
tioning was as follows:
DG ¼ DGH1DGEL1DGS1C: (4)
DGH accounts for the variations of the water/nonwater interface area,
calculated as the product of the solvent-accessible surface area (calculated
by rolling a sphere with a radius of 1.4 A˚ along the surface of the molecule)
by surface tensions (30 cal/mol/A˚2). DGEL is the sum of the DGDESOLV
(resulting from desolvation of partial charges transferred from aqueous
medium to the receptor-binding cavity) and DGCOUL (coulombic interac-
tions between ligand and protein). DGS is composed of two terms—DGSSC
and DGSL. DGSSC represents the decrease in conformational freedom of the
functional groups buried upon complexation. This term is calculated for each
side chain from its solvent-accessible surface. DGSL represents the loss of
degree of freedom of torsion angles in the ligand upon complexation (0.5 3
number of frozen variables) (37). The term C is a constant term that reflects
the changes of the entropy of the system due to a decrease in the concen-
tration of free molecules (cratic factor) and loss of rotational/translational
degrees of freedom. The following protocol was used for binding energy
calculations (49):
1. The energy of the system was optimized by the ICM local minimization
procedure.
2. ICM double-energy minimization was performed for relaxing the
solvent-accessible side chains.
3. The target and ligand were separated.
4. The ligand torsion angles were unfixed according to the stereochemical
considerations followed by MC simulation.
5. For the target, the solvent accessible side chains within 4 A˚ of the
interaction interface were relaxed.
MD simulations and LIE analysis
MDswere performed both for TFE and PYR in complexwith the three possible
enzyme models of DlADH and DmADH bound to the coenzyme. For LIE
analysis, it is necessary to perform separate MDs of target-ligand complexes
and the ligands. The SANDER module of the AMBER suite of programs was
used for MD. The Cornell et al. (50) force field was used for amino acids,
whereas the generalized force field (51) was used for the inhibitors.
The active forms of DlADH and DmADH are dimers of two identical
subunits (254 and 255 amino acids, respectively). In both enzymes, the
active site of one subunit is closed by the C-terminal end (amino acids 250–
254, DlADH nomenclature) of the other subunit (11,52). To reduce
computational time, MDs were performed for 750 ps with one subunit.
However, to test if such a simplification could affect the LIE calculations,
MD simulations for 5 ns with subsequent LIE analyses were also performed
for dimeric ternary complexes of TFE and PYR with both DlADH and
DmADH (ionization scenario C; Ser-OH=Tyr-O=Lys-NH13 ).
Target and ligand preparation for MD
The x-ray crystallographic structure ofDlADHNAD1TFE (PDB ID: 1SBY)
was used as the input structure for the simulations of TFE with the different
charge scenariomodels ofDlADH.The starting structures of TFE for theMDs
with DmADHwere created by superimposing the DlADHNAD1TFE x-ray
structurewith the slowallelo formDmADHNADHacetate (PDB ID: 1MG5)
x-ray structure. The startingmodelswith PYRwere created by superimposing
PYRon top of the TFE structure in the complexeswithDlADHandDmADH.
The LEAP module of AMBER was used to add hydrogen atoms to enzyme
models and to build the PYR structure.
The AMBER force fields lack atomic charges and parameters for NAD1,
TFE, PYR, and the deprotonated amino acids Tyr and Ser. Models of these
chemical entities were initially minimized by the SANDER module of
AMBER, followed by optimization with AM1-BCC (53). Electrostatic poten-
tials were calculated quantummechanically with theGaussian98 program (54),
using the HF/6-31G* basis set. The ANTECHAMERmodule of AMBERwas
then used to obtain restrained electrostatic potential-based charges (55).
MD protocol
Most of the calculations were performed using four processors on an HP
Superdome (Hewlett Packard, Palo Alto, CA) with 550 MHz, but some were
performed with Xeon 2 processors (Intel, Santa Clara, CA). All-atommodels
of the two inhibitors and the target-ligand complexes were solvated by a
rectangular box of TIP3P water molecules (56) and neutralized by adding
counterions. The water molecules were ;10 A˚ from the solute atoms in all
directions (;10,000 waters for monomeric complexes, ;16,000 for the
dimeric complexes, and ;500 for the inhibitors). An identical solvation
FIGURE 3 2, 2, 2-trifluoroethanol (TFE) and 1H-PYR.
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protocolwas used for all molecular systems. The particlemesh Ewaldmethod
(57) and periodic boundary conditionwere applied for calculating long-range
electrostatic interactions. The SHAKE option (58) with a tolerance of 106
and Berendsen temperature coupling (59) were applied to fix all the bonds
involving hydrogen atoms. The time step was 1 fs. A nonbonding cutoff
radius of 9 A˚ was also applied during the MDs. The nonbonded pair list was
updated every 15 steps. Trajectory and structure analyses were performed by
the CARNAL and ANAL modules of AMBER, and visualization was
performed by ICM and visual molecular dynamics (60).
The molecular systems were energy minimized for 2500 cycles, initially
by the steepest decent method then by the conjugate gradient method, to
remove steric contacts. The obtained complexes were equilibrated for 50 ps
by constant volume dynamics followed by 600 ps constant pressure solute
equilibration at 1 atm. The temperature fluctuations and the potential
energies were monitored during the equilibration period. After equilibration,
100 ps production MD was performed, giving a total MD time of 750 ps.
The coordinate sets were collected every 0.2 ps during the production MDs,
which were used to calculate the free energies of binding by the LIE method.
Using scenario C (Ser-OH=Tyr-O=Lys-NH13 ), the ternary ENAD1
inhibitor complexes were simulated for 200 ps constant volume dynamics,
followed by 4.8 ns constant pressure dynamics to study the atomic fluc-
tuations in both the ligand and the enzyme during dynamics. The trajectories
between 840 ps and 5 ns were used for LIE analyses.
Calculation of binding energies with the
LIE method
The value of the LIE method is in the linear response approximation of
the electrostatic contribution to the free energy of binding. The nonpolar
contribution is estimated by using an empirically derived parameter that
scales intermolecular vdW interactions from MDs. Two MDs are required:
one for the free ligand in solution and another for the target-ligand complex
in solution. The LIE equation is as follows:
DGbind ¼ aDÆVvdWl-s æ1bDÆV
el
l-sæ1 g: (5)
Ææ Denotes MD or MC averages of the nonbonded vdW and electrostatic (el)
interactions of the ligand and its surrounding environment (l-s).D indicates the
change of average energies between the target-bound and -free states of the
ligand. TheANALmodule ofAMBERwas used to decompose the total energy
of interactions between the ligand and its surroundings into the vdW and
electrostatic contributions. Thea- andb-values are coefficients for thenonpolar
and polar contributions, respectively, and g is a constant term. The coefficients
of the LIE equation were adopted fromHansson et al. (61) (a¼ 0.181 for both
inhibitors, b ¼ 0.37 and 0.43 for TFE and PYR, respectively, and g ¼ 0).
HINT scoring
The HINT force field was used for binding energy prediction based on
experimentally determined LogPoctanol/water values. Therefore, HINT esti-
mates not only the enthalpic but also the entropic contributions to the free
energy of binding. All noncovalent interactions (hydrogen bonds, acid-
base, hydrophobic-hydrophobic, acid-acid, base-base, hydrophobic-polar)
are analyzed and scored using the same mathematical protocol. The parti-
tion method for protein is dictionary (62) by which HINT calculates the
LogPoctanol/water based on residue type and solvent condition. Ligands are
usually analyzed by an approach adopted from Hansch and Leo’s CLOG-P
method (63). The total HINT score is the sum of all atom-atom interactions
(42). As different ionization patterns were analyzed, the inferred option was
used as the solvent condition to automatically choose the state of each amino
acid in the protein. The HINT option that corrects the Si terms for backbone
amide nitrogens (64) by adding 20 A˚2 was used in this study to improve the
relative energetics of inter- and intramolecular hydrogen bonds involving
nitrogens. HINT scores were calculated using the ‘‘all’’ options, which treat
all hydrogens explicitly.
The HINT calculation was performed on the monomeric complexes from
MDs and on the dimeric complexes generated by ICM docking. The
optimum pH level of inhibitor binding to the enzymes may not correspond to
the pH at which crystallographic structures were solved or binding analyses
were experimentally performed. HINT scores suggest a significant corre-
lation between the experimental and computational titration curves, leading
to the identification of the best HINT score model as the most probable
protonation state (65). Unlike the binding energies calculated by ICM and
LIE, a more positive HINT score indicates stronger interaction.
RESULTS AND DISCUSSION
The DADHs have been extensively studied by enzyme
kinetics, structural, mutagenesis, and computational studies,
and a lot of experimental data have been generated. The
structural and mechanistic similarities within the SDR family
indicate that the DADHs are valuable model systems for
studying the structure-function relationships of SDRs. In this
study, theoretical calculations were used to gain insight into
the ionization scenario upon inhibitor recognition and bind-
ing. Theoretical calculations of target-ligand binding affin-
ities contribute molecular insight into the binding process
and complement the macroscopic properties measured by
experimental studies. The basic mechanisms behind the
effects of biologically active molecules involve a process of
molecular recognition and complexation. The electrostatic
contribution to the process is very important.
The structural and functional similarities within the SDR
family indicate that the ionization of highly conserved
catalytic residues at the active site is similar for most of the
enzymes within the family. The calculations of DlADH and
DmADH with PYR and TFE (both inhibitors form dead-end
complexes with the two enzymes (21,27,30,66,67)) should
give identical conclusions. The ionization scenario giving
the highest HINT score (highest positive value), strongest
ICM binding energy (most negative value), and a LIE free
energy of binding closest to the experimental binding energy
(Table 1) is considered the most probable scenario when
inhibitors bind to the binary ENAD1 complex of SDRs.
Ranking the ligand binding affinities by molecular mod-
eling is challenging and important for guiding drug design.
Most of the scoring functions developed for ranking protein-
ligand poses are based on known 3D structures of both pro-
teins and ligands. The number of known 3D structures is still
small, which limits the generation of empirical parameters for
the scoring functions. Therefore, a scoring function works
best for a set of ligands which are structurally related to the
training set of the program.
ICM docking, binding energy calculations,
and HINT scoring before MD
ICM has previously been found to identify active ligands in
virtual screening studies and to reproduce x-ray crystallo-
graphic protein-ligand binding poses (68), indicating that
ICM is a valuable tool for docking small molecular enzyme
1416 Gani et al.
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inhibitors. Therefore, the ICM program was used for auto-
matic docking and scoring.
The topology of the alcohol binding cavity in the
DADHNAD1 complex was first predicted from kinetic stud-
ies with well-defined alcohols (15,66,69,70). The prediction
was confirmed and further refined by x-ray crystallographic
data from studies of DlADH (11). Briefly, the binding cavity
of the DADH is hydrophobic and bifurcated dived into the R1
and R2 pockets based on the interactions with the alkyl chains
of secondary alcohols. The R1 pocket is longer than the R2
pocket (10 A˚ at its longest) and further subdivided into R1(a)
and R1(b), whereas R2 is wider than R1.
In this study, the criterion for discriminating the docking
poses was similarity with the ligand-binding mode observed
in the x-ray crystallographic complex of DlADH (1SBY). In
three of the four different ionization scenarios of DlADH,
;15 of the 20 poses suggested by the docking program were
in agreement with the crystallographic pose, as indicated by
the root mean-square deviation (RMSD) values in Table 2.
However, for ionization scenario D, where the catalytic triad
was fully protonated (Ser-OH=Tyr-OH=Lys-NH13 ), no ac-
ceptable binding poses were observed. This is in agreement
with the kinetic studies indicating that alcohols and alcohol
competitive inhibitors bind only to a binary DADHNAD1
complex that has lost a proton at the active site (Fig. 2) and
not to a complex where all three amino acids of the catalytic
triad are protonated (27,28,30,71). Thus, the ICM docking
results here must be regarded as reliable for DlADH and
DmADH and hence gave a plausible picture of the ionization
state of the catalytic triad. The binding poses where the
ligands showed strongest interactions with the surrounding
amino acids are shown in Table 2. Both subunits of the
enzymes were included during the docking process and in
the subsequent calculations of binding energies.
The ICM and HINT scoring indicated that TFE binds
more strongly to the DADHNAD1 complex than to PYR
(Table 2). This is contrary to what the experimentally derived
data show (Table 1). PYR and TFE differ in structure, size,
and polarity, indicating that their intrinsic errors during the
docking process also should differ (Fig. 3). Therefore, it
could not be expected that the ranking between PYR and
TFE would be in agreement with the experimental observa-
tions. The main goal in this study was to determine the
ionization scenario that binds the two dead-end inhibitors.
Based on the experimental observations, the scenario should
be similar in both enzymes for both inhibitors. Therefore,
the ICM and HINT scorings were used to obtain a ranking of
the PYR-enzyme complexes relative to each other and of the
TFE-enzyme complexes relative to each other. The best-
scored scenario among four different sets of target-inhibitor
complexes (DmADHNAD1PYR, DlADHNAD1PYR,
DmADHNAD1TFE, and DlADHNAD1TFE) was con-
sidered the most probable when an inhibitor binds to the
binary ENAD1 complex.
Comparison between the experimentally determined and
ICM calculated binding energies of TFE for DADHs showed
that the ICM calculations strongly overestimated the bind-
ing energies with ;3.5 to 5 kcal/mol (Tables 1 and 2).
Despite this overestimation, the poses characterized by the
strongest TFE interaction to the binary DlADHNAD1 com-
plex (Table 2) were very similar to the binding pose of TFE
in the x-ray crystallographic structure. Scenario A, with both
Ser-138 and Tyr-151 deprotonated, did not reproduce the crys-
tallographic binding pose of TFE to the binary DlADHNAD1
complex as well as scenario C (Ser-OH=Tyr-O=Lys-NH13 )
and scenario B (Ser-OH/Tyr-O/Lys-NH2) did. The TFE
docking poses with scenarios B and C were nearly 100%
similar to the x-ray crystallographic binding pose of TFE to
the binary DlADHNAD1 complex. Both the ICM and
HINT scoring ranked scenario C as the best (Table 2 and
Scheme 2). The 3D structure of the ternary complex of TFE
with DmADHNAD1 has not been experimentally deter-
mined. However, the ICM and HINT calculations here led
to similar conclusions as those for the DlADH complex, with
C as the best-ranked scenario (Table 2 and Scheme 2).
So far, no experimental 3D structures of a DADH
NAD1PYR complex have been reported. Hence we could
not compare the docked complex with an experimentally
derived structure. In this work, both ICM and HINT scoring
ranked scenario B as the best for DmADH and scenario C as
the best for DlADH (Table 2 and Scheme 2). Comparison
between the experimentally determined (Table 1) and ICM
calculated binding energies (Table 2) of PYR for DADHs
showed that the ICM calculations reproduced the experimen-
TABLE 2 ICM binding energy (kcal/mol) and the corresponding HINT score for binding PYR and TFE to the enzyme models with
different ionization scenarios at the active site
DmADH DlADH
PYR TFE PYR TFE
Ionization scenario ICM HINT ICM HINT ICM HINT ICM HINT
A: Ser-O=Tyr-O=Lys-NH13 4.34 113 6.93 390 4.13 23 7.13 (0.66) 1148
B: Ser-OH/Tyr-O/Lys-NH2 6.21 575 7.82 649 5.07 229 8.25 (0.00) 605
C: Ser-OH=Tyr-O=Lys-NH13 4.98 79 8.24 653 6.11 609 8.32 (0.03) 654
D: Ser-OH=Tyr-OH=Lys-NH13 NB NB NB NB
Values in parenthesis are the RMSD values in A˚ of the heavy atoms of TFE from the x-ray crystallographic structure (PDB ID: 1SBY) for that particular
pose. NB denotes ‘‘not bound’’.
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tally determined energies which were in the range from5.7
to 7.3 kcal/mol.
To summarize the ICM and HINT scoring of the complexes
before MDs, scenario C was shown as the best in six out of
eight rankings, whereas two of the rankings showed scenario
B as the best (Table 2 and Scheme 2). Thus, based on the ICM
binding energy and the HINT scoring before MD simulations,
scenario C is regarded as the most probable ionization of the
catalytic amino acids in the binary DADHNAD1 complex to
which the inhibitors, and hence alcohols, bind.
MD simulations
Completeness of equilibration
To obtain reliable and thermally averaged energies for the LIE
analysis, the MDs must be sufficiently long. In this study, the
vdW and electrostatic contributions to ligand binding be-
tween 650 and 750 ps of MDs were used for the LIE analysis
of the monomeric complexes, and the corresponding interac-
tions between 840 ps and 5 ns were used for dimeric com-
plexes. During the MD equilibration period, the fluctuations
of potential, kinetic, and total energy, temperature, pressure,
and volume of the molecular systems were monitored to
ensure that the systems were fully equilibrated before the
production phase. Table 3 shows the nonbonded interactions
between 650 and 750 ps of the MDs with the monomeric
enzyme with scenario C. These values indicated that the
nonbonded energy converged within the MD period, giving a
stable average of the binding energy.
van der Waals and electrostatic interactions
A fundamental assumption for the LIE approach is that the
nonpolar contributions to the free energy of binding can be
estimated by using empirically derived parameters, whereas
the electrostatic contribution to the free energy of binding is
linearly approximated. Three statistical normality tests
(Ryan-Joner, Anderson-Darling, and Kolmogorov-Smirnov)
were performed for the vdW interactions between a ligand
and its surroundings in all scenarios (72). The p-value was
,0.01 for vdW interactions, which indicates that the
interaction energies departed significantly from normality.
This observation supports the assumption that the parameter
a in Eq. 4 should be derived empirically. Similar tests for the
electrostatic interactions did not indicate significant depar-
ture from normality, supporting the LIE approach that the
electrostatic interaction parameter is linearly related.
As the vdW interactions of the ligand with the surrounding
amino acids were not normally distributed, a nonparametric
analysis of variance (ANOVA) (Kruskal-Wallis) test was
performed using MINITAB 14 (73) to study the possible
differences in medians of target-ligand vdW interactions in
different ionization scenarios. This indicated a highly
significant difference in medians (p ¼ 0.000) between the
different ionization scenarios for both ligands, denoting that
the ligands showed significantly different vdW interactions
TABLE 3 Average vdW and electrostatic interaction energies (kcal/mol) between the ligand and the surroundings (DADH and
solvent molecules) in the ternary complexes at different time intervals during the 750 ps MDs with the Ser-OH=Tyr-O=Lys-NH13
scenario using one subunit
Time (ps)
Ligand Interaction DADH 650–700 700–750 650–750
PYR vdW DlADH 11.55 (1.76) 11.27 (1.57) 11.41 (1.67)
DmADH 10.82 (2.07) 11.48 (2.91) 11.15 (2.02)
electrostatic DlADH 13.35 (2.23) 14.03 (2.21) 13.69 (2.25)
DmADH 15.17 (4.01) 17.26 (3.85) 16.21 (4.06)
TFE vdW DlADH 9.53 (2.25) 9.51 (2.16) 9.52 (2.20)
DmADH 9.64 (2.36) 9.91 (2.09) 9.78 (2.23)
electrostatic DlADH 19.61 (2.64) 19.65 (2.72) 19.56 (2.56)
DmADH 18.45 (2.48) 18.40 (2.34) 18.42 (2.41)
Values in parentheses show standard deviations (SD) from the mean value. The MD simulations with the other scenarios followed a similar trend.
SCHEME 2 Summary of theoretical calculations. Scenario D is not
included in the ranking.
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with the surrounding environments in these scenarios. The
parametric tests, one-way ANOVA and the Dunnett test, for
electrostatic interactions indicated significant difference (p¼
0.000) among the ionization scenarios. These tests support
the scope of the LIE method and the use of the LIE method
for the molecular systems in this study.
LIE analysis
LIE calculations have previously been found to satisfactorily
reproduce experimental binding energies of severalmolecular
systems (39–41). Therefore, it could be expected that a
theoretical ionization scenario corresponding to the actual
ionization of the residues at the active site would result in a
calculated binding energy that correlates with the experimen-
tal obtained value. However, when a modeled ionization
scenario deviates from the real ionization scenario, the cal-
culated binding energy will also deviate from the experimen-
tally obtained value. The theoretical binding energy will be
either larger or smaller than the experimental value, depend-
ing on the charge distribution of both the unnatural modeled
scenario and the ligand. The calculations of the LIE values are
based on MD trajectories, and during MD even an unnatural
scenario may adopt favorable interactions with the inhibitor
structure and obtain favorable LIE values. Using the LIE
approach for calculating protein-ligand complexwith charged
groups (binding site and ligand) at the binding interface is
challenging (74). The absolute binding energy is the differ-
ence between the desolvation energy and the protein-ligand
complex energy. The LIE approach uses an explicit solvation
model, such that the desolvation free energy should be quite
reasonably handled. However, charged ligands and charged
binding sites correspond to large desolvation and protein-
ligand complex energies; and therefore, the calculation of the
absolute binding energy may adopt large numerical errors.
In this study we compared binding site architectures with
different charge distribution and ligands with different
polarity. The differences in the number and distribution of
charged groups between the scenarios and the differences in
polarity and the size between PYR and TFE may result in
different intrinsic errors between the scenarios and between
PYR and TFE in the calculation of LIE values (Table 4). The
LIE approach is therefore not straightforward for our
molecular systems. Our approach was therefore to evaluate
the ionization scenarios for each inhibitor separately, and the
scenario with the LIE value closest to the experimental
binding energies in Table 1 (pH range 6–10) was considered
the most probable.
As shown in Table 4, LIE values for PYR binding to
scenario C were in the range of the experimentally obtained
binding energies for both DADHs. The LIE values of 6.78
kcal/mol for DmADH and 6.47 kcal/mol for DlADH are
well within the range of the experimentally obtained energies
of 6.0 to 7.3 kcal/mol and 5.7 to 6.7 kcal/mol, re-
spectively. The differences in experimentally derived binding
energy between the two enzymes are also reflected in the LIE
values. The LIE values for scenarios A and B were outside the
experimentally derived values for both the enzymes, although
scenario B is much closer than scenario A.
As for ICM, the LIE values for TFE binding deviated
largely from the experimentally determined binding energies.
Contrary to the experimental data, the LIE values also
indicated that TFE binds more strongly than PYR to both
DADHs. Table 3 indicates that the main reason for that were
stronger electrostatic interactions. On average, PYR exhibited
;2 kcal/mol stronger vdW interactions than TFE did with
the enzymes during 650–750 ps of MDs. This difference is
comparable to the experimental observations (Table 1) that
indicated ;3 kcal/mol stronger binding of PYR than TFE
(Table 1). However, for the electrostatic interactions, this was
completely reversed (Table 3). The polar TFE corresponds to
larger desolvation energy than the stable ring system of PYR,
and the calculated LIE values may give larger numerical
errors. This suggests that different LIE parameters should be
used for TFE and PYR. Scenario C gave the LIE values that
were the least overestimated for both enzymes.
Except for the monomeric PYR-DmADH complex, the
calculated binding energies of scenario C were stronger after
5 ns of MD with both subunits than after MD with the
monomeric enzyme forms. The inhibitors also bound with
similar strength to both subunits (Table 4). The reason, most
probably, is that the C-terminal of subunit A participates in
binding the ligand to subunit B and vice versa, as seen in the
x-ray crystallographic structures (10,11). This indicates that
different g-values might be used for monomeric and dimeric
LIE calculations of DmADH and DlADH.
In summary, the LIE analysis indicated that scenario C
gave LIE values closest to the experimental observation and
hence scenario C is regarded as the most probable ionization
of the catalytic triad in the binary DADH-NAD1 complex
that binds inhibitors and alcohols.
HINT scoring after 750 ps MD
The complexes showing the highest HINT scores represent
the ionization state and the protonation level most favorable
for the protein-ligand binding process (75). The HINT scores
indicated that there was a consistent rise-up of the predicted
binding energies for the two first added protons and a sharp
drop-off for the third proton positioned on Tyr-151 (Table 5).
This behavior is similar to that of a kinetic titration curve and
suggests that the optimum binding coincides with the
number of added protons at the maximum HINT score.
The HINT scores indicated that scenario C showed optimum
binding in all cases, except for TFE binding to DmADH.
However, the values for scenarios C and B were very close
(544 vs. 548). Based on the HINT scores after MDs, scenario
C should be considered the most probable when the
inhibitors interact with their target and thereby confirm the
ICM and HINT scoring on the complexes before MDs.
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Hydrogen-bonding pattern during MD simulations
The local pH and thereby the ionization states of the catalytic
triad strongly influence the free energy of ligand binding and
the target-ligand hydrogen bonds. Computational drug design
and virtual screening of databases against protein targets are
most often carried out without considering local pH or
ionization states of amino acids or ligands. Very often, the pH
for crystal growing and the optimum pH for ligand binding do
not correspond to each other and thus give different binding
patterns. Proton migration across hydrogen bonds is also
identified as a probable mechanism for biological activity
(76). Understanding the molecular features caused by the
local pH and the hydrogen-bond patterns is therefore im-
portant for understanding the molecular mechanism of target-
ligand interactions.
A clear pattern of hydrogen bonds was observed during
the MDs. Hydrogen bonds between the ligand and the
enzyme models were monitored during the final 100 ps of the
750 ps MDs of the monomeric complexes. The percentage
occupancy of the hydrogen bonds was calculated as the
percentage of the sampled coordinate sets during the period
with the particular hydrogen bond present (atomic distance
,3.1 A˚). The hydrogen bonds in Tables 6 and 7 suggest the
following:
a. In ionization scenarios A and B, the ligands formed stable
hydrogen bondsmainly with one of the surrounding amino
acids (mostly Tyr, or either Ser or Thr). In these two
scenarios, only one nitrogen atom (N1-H) of PYR was
involved in hydrogen bonding. Only scenario C exhibited
dynamic hydrogen bonding, where Tyr-O remained
hydrogen bonded to the proton-donating atom of the
inhibitor during the final 100 ps of MD. However, this
particular hydrogen bond was also observed for the other
enzyme models with Tyr-O. The MDs of TFE with
scenario C indicated that a stabilizing hydrogen bond
could be formed between TFE-OH and ribose-O29 atom,
whereas PYR was stabilized by the OH group of Ser-138.
b. At the active site of DlADH, both PYR and TFE ex-
hibited more favorable hydrogen bonds than that ob-
served with DmADH. With DlADH, dynamic hydrogen
bonds were formed between the inhibitors and Tyr,
Ser, and possibly ribose-O29. Of the two inhibitors, TFE
seemed to exhibit the most favorable (in terms of occu-
pancy) hydrogen bonds.
c. During the MDs with the dimer, the active site of the two
subunits showed some differences in hydrogen bonds
with the ligands. In DmADH, subunit A exhibited a
higher hydrogen-bond occupancy than subunit B, whereas
in DlADH the differences between the subunits were less
pronounced.
d. During the MDs with scenario C and an inhibitor, a
lower hydrogen-bond occupancy was observed with one
subunit than with both subunits. The reason for this was
that the C-terminal end of one subunit also contributes to
the active site (R2 pocket) of the second subunit.
e. The hydrogen-bonding pattern at the active site indicated
that Tyr-151 is the base for proton extraction. Further-
more, Ser-138 (in both DmADH and DlADH) and
possibly NAD1 ribose-O29 (with TFE) and Thr-140 (with
PYR) were involved in dynamic hydrogen bonds that
stabilized the ligand at the binding site.
Determinants of ligand-receptor interactions
The volume of the binding pockets of DmADH and DlADH
are similar (;461 A˚3 and ;458 A˚3, respectively) and is
mainly occupied by a NAD1 molecule in the binary com-
plexes. The R1 pocket is mainly hydrophobic and formed by
hydrophobic amino acids in the helicesa1 (Phe-192, Val-189),
a2 (Val-202, Leu-206), the N-terminal end of aF (Val-148),
b1-strand (Ile-183), two amino acids (Leu-95 and Ile-145) in
the loop regions, and NAD1 (atom C7N) (Fig. 1). The shorter
but wider R2 subpocket is formed by the following amino
acids: Val-139 and Thr-140 in 310-helix between bE and aF,
TABLE 5 HINT scoring of PYR and TFE in the ternary
complexes after 750 ps MD simulations
DmADH DlADH
Ionization scenario PYR TFE PYR TFE
A: Ser-O=Tyr-O=Lys-NH13 532 536 360 442
B: Ser-OH/Tyr-O/Lys-NH2 468 548 458 391
C: Ser-OH=Tyr-O=Lys-NH13 717 544 559 572
TABLE 4 Binding free energies (kcal/mol) calculated by the LIE method
DmADH DlADH
Ionization scenario PYR TFE PYR TFE
A: Ser-O=Tyr-O=Lys-NH13 * 12.09 9.0 8.52 8.85
B: Ser-OH/Tyr-O/Lys-NH2* 8.06 7.99 7.02 8.39
C: Ser-OH=Tyr-O=Lys-NH13 * 6.78 7.79 6.47 7.58
C: Ser-OH=Tyr-O=Lys-NH13
y 7.03z/6.50§ 7.99z/8.35§ 7.85z/7.89§ 8.40z/7.60§
*Energy after MD of the monomer (subunit A).
yenergy after MD of the dimer.
zsubunit A.
§subunit B.
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Pro-181 (backbone O) in bF, Gly-182 (backbone O and Ca)
and Ile-183 (backbone N) between bF and b1, and Trp-250
from the other subunit. Although the amino acids lining the
active site of DmADH and DlADH are 100% conserved, the
active site of DlADH is more electropositive than that of
DmADH (12,77). We observed that the N-terminal part that
contains the active site is more electronegative, whereas the
C-terminal part is more electropositive (Fig. 4 A); so the
subunit association regions are electrostatically complemen-
tary to each other (Fig. 1). In the binary DlADHNAD1
complex (PDB ID: 1A4U), the entire region, except for the
region near Lys-155, has a negatively charged electrostatic
surface (Fig. 4 B). But in the ternary complexes of both
DmADH and DlADH, only the adenine binding part was
electronegative (Fig. 4 C). In these complexes, the nicotin-
amide binding site is slightly electronegative, whereas the
ribose binding region is strongly electropositive, indicating a
positively charged surface in the region of Lys-155. This
positively charged surface indicates that scenario B is less
likely.
The ICM docking and HINT scores indicated that the most
probable ionization scenario of the catalytic triad after the
proton release from the binary complex is scenario C. To
check if the simplification of using one subunit for MDs and
LIE analyses biased the calculations, 5 ns MDs were per-
formed for the ternary dimeric complexes of both enzymes
TABLE 7 Observed hydrogen bonds (atomic distance\3.1 A˚) between the ligand and the amino acids of DmADH during
650–750 ps of MD simulations
TFE PYR
Ionization scenario Donor/acceptor Occupancy (%) Donor/acceptor Occupancy (%)
A: Ser-O=Tyr-O=Lys-NH13 TFE/Tyr-152 100 PYR-N1/Ser-139 100
PYR-N1/Thr-141 28.4
B: Ser-OH/Tyr-O/Lys-NH2 TFE/Tyr-152 100 PYR-N1/Tyr-151 99.6
C: Ser-OH=Tyr-O=Lys-NH13
y NAD-O29/TFE 51.4 Ser-139/PYR-N1 71.6
TFE/NAD-O29 34.7 PYR-N1/Tyr-151 99.6
TFE/Tyr-152 100
C: Ser-OH=Tyr-O=Lys-NH13
z TFE/Tyr-411 100 Ser-396/PYR-N1 31.6
PYR-N1/Ser-3946 19.6
PYR-N1/Tyr-409 100
Hydrogen bonds observed in .20% of the sampled coordinate sets are included. Occupancy indicates the percentage of sampled coordinate sets with that
particular hydrogen bond shorter than 3.1 A˚.
ysubunit A of the dimer.
zsubunit B of the dimer.
TABLE 6 Observed hydrogen bonds (atomic distance\3.1 A˚) between the ligand and the amino acids of DlADH during
650–750 ps of MD simulations
TFE PYR
Ionization scenario Donor/acceptor Occupancy (%) Donor/acceptor Occupancy (%)
A: Ser-O=Tyr-O=Lys-NH13 TFE/Tyr-151 100 PYR-N1/Ser-138 90.4
PYR-N1/Thr-140 64.6
B: Ser-OH/Tyr-O/Lys-NH2 Ser-138/TFE 19.8 PYR-N1/Ser-138 52




y NAD-O29/TFE 32.4 Thr-140/PYR-N1 29.2
Ser-138/TFE 26.4 Ser-138/PYR-N1 85.6
TFE/Tyr-151 100 PYR-N1/Tyr-151 68
TFE/NAD-O29 26.8
C: Ser-OH=Tyr-O=Lys-NH13
z NAD-O29/TFE 32 Ser-394/PYR-N1 52.4
Ser-394/TFE 20.8 PYR-N1/Ser-394 24.8
TFE/Tyr-407 100 PYR-N1/Tyr-407 94
TFE/ NAD-O29 28.8
Hydrogen bonds observed in .20% of the sampled coordinate sets are included. Occupancy indicates the percentage of sampled coordinate sets with that
particular hydrogen bond shorter than 3.1 A˚.
ysubunit A of the dimer.
zsubunit B of the dimer.
Modeling the Catalytic Triad of SDRs 1421
Biophysical Journal 94(4) 1412–1427
using scenario C. Important atomic distances between the
target and the inhibitors were studied during the MDs.
MD of DlADHNAD1PYR: The overall RMSD of
backbone atoms between the starting and final structures
from 5 ns of MD was 0.97 A˚ and 1.28 A˚ for subunits A and
B, respectively (Fig. 5, A and B). The largest differences
were seen in the 3–10 helix situated between aE and aE and
in the C-terminal part of each subunit lining the binding site
region of the neighboring subunit. The RMSDs of the
backbone atoms of the 3–10 helix between the initial and
final structures were between 1 and 1.5 A˚, whereas the cor-
responding RMSDs for C-terminal amino acids were ;1.5
A˚. The 3–10 helix is rather distal to the active site and should
not affect the ligand binding. But the C-terminus lines the
binding pocket of the other subunit; therefore fluctuations in
this region can affect the ligand position at the active site. In
subunit B, the ligand binding induced an RMSD of .1 A˚
between the initial and the final structures of the amino acids
in the a1 helix (Leu-207 and Ser-208) and in the a2 helix
(Pro-187, Leu-188, Val-189, and His-190). These amino
acids are located at the active site. In the starting complex,
the PYR ring was coplanar to the nicotinamide moiety of
NAD1. During MD, the plane of the PYR ring was changed
to a perpendicular position (Fig. 5 A), which also is observed
in the x-ray crystallographic structure of the horse liver
ADHNAD1PYR ternary complex (78,79). The planarity of
the PYR ring was changed around 1275 ps of MD and
fluctuated around a perpendicular position relative to NAD1
for the remaining simulation period (Fig. 5 B). The atomic
distance between PYR-N2 and NAD-C4 and between PYR-
N1 and Tyr-O remained almost stable during the MD
period. But the distance between PYR-N1 and Ser-OH
changed abruptly at ;1275 ps. Similar movements were
observed in both subunits of DlADH. In both subunits, the
N1-H group of PYR was directed toward the Tyr-O, which
indicated that the partly positive charge at the C4 atom of the
nicotinamide moiety is the main factor for binding PYR-N2
and for the orientation of PYR inside the binding cavity.
MD of DmADHNAD1PYR: The RMSD of backbone
atoms between the starting and final structures of 5 ns of
MD was 0.88 A˚ and 1.06 A˚ for subunit A and subunit B,
respectively. None of the active site residues had an RMSD
FIGURE 4 Electrostatic surface of the x-ray structure of DlADH. The
most electronegative surfaces are in red, whereas the most electropositive
areas are in blue. (A) Electrostatic surface of the entire monomeric DlADH.
(B) Closer view of the NAD1 binding region in the apo form of DlADH
active site, viewed as in A. NAD1 is shown in a position that corresponds to
the position in the binary x-ray crystal structure complex. The NAD1 mol-
ecule is shown as a stick model and colored according to atom type (carbon-
yellow, nitrogen-blue, oxygen-red). A cutting plane has been inserted in the
region of the NAD1 molecule, and the NAD1 bond that is missing in the
figure is due to the cutting plane. (C) A closer view of the electrostatic surface
of the nicotinamide and ribose binding regions of the active site cavity of
the ternary x-ray crystallographic complex DlADHNAD1TFE (PDB ID:
1SBY). The nicotinamide-binding site is slightly electronegative, whereas the
ribose-binding region is strongly electropositive.
1422 Gani et al.
Biophysical Journal 94(4) 1412–1427
from the initial structure of more than 1 A˚ after MD. As in
the MD of DlADH, the PYR ring was changed from a
coplanar to a perpendicular orientation relative to the
nicotinamide moiety of NAD1. This change was seen at
;580 ps for subunit A and slightly later for subunit B. In
contrast to the MDwith DlADH, the PYR ring did not stay in
a stable perpendicular position relative to NAD1 for the rest
of the MD period but changed between coplanar and per-
pendicular orientations. However in most of the sampled
coordinate sets, the ring was observed in a perpendicular
orientation. The atomic distances between PYR-N2 and
NAD-C4 in the DmADH complex (Fig. 5 B) were less stable
than the corresponding distance in DlADH during the MD,
which reflects the continuous changes between a coplanar
and a perpendicular orientation of the PYR ring.
MD of DADHNAD1TFE: The overall RMSD of
backbone atoms between the starting and final structure of
5 ns of MD was 0.92 A˚ and 2.61 A˚ for subunit A and subunit
B, respectively (Fig. 6, A and B). The distances from TFE-O
to Tyr-O, Ser-OH, and NAD1-C4 were consistently
fluctuating around ;2.5 A˚, ;4.5 A˚, and ;3.5 A˚, respec-
tively, in both subunits (Fig. 6 B). Similar fluctuations were
also observed during the MD with DmADH. The most
significant movement observed in both subunits of the
enzymes was the movement of the C1-atom of TFE. In the
starting position for MD, HS and HR of C1 of TFE were 4.3
A˚ and 7.4 A˚ from the NAD1-C4, which closely resembles
the x-ray crystallographic mode. After 5 ns MD, C1 was
changed from its starting position by a rotation of the axis
FIGURE 5 Ternary DlADHNAD1PYR complex with the Ser-OH=
Tyr-O=Lys-NH13 ionization scenario of the catalytic triad after 5 ns of MD.
(A) Amino acids lining the R1 (wire model in green) and R2 (wire model in
blue) subpockets of the active site. The nicotinamide and ribose ring of
NAD1, the catalytic triad (Ser-138, Tyr-151, and Lys-155), and PYR are
shown as stick models with coloring according to the atom type (carbon-
yellow, nitrogen-blue, oxygen-red, and hydrogen-gray). The ribbon repre-
sents the C-terminal loop of the other subunit acting as a lid of the active site
cavity. PYR is shown both before and after the 5 ns of MD. The ring was
parallel to the nicontinamide ring of the NAD1 ring at the start of the MD
but tilted to perpendicular during the MD. (B) Fluctuation of atomic dis-
tances between PYR and atoms of the active site during the MD.
FIGURE 6 Ternary DlADHNAD1TFE complex with the Ser-OH=
Tyr-O=Lys-NH13 ionization scenario at the active site. (A) Amino acids
lining the R1 (wire model in green) and R2 (wire model in blue) subpockets
of the active site. Only selected active site residues are included. The
nicotinamide and ribose ring of NAD1, catalytic triad (Ser-138, Tyr-151,
and Lys-155), and TFE are shown as stick models colored according to the
atom type (carbon-yellow, nitrogen-blue, oxygen-red, and hydrogen-gray).
(B) Fluctuation of atomic distances between TFE and atoms of the active site
during the MD.
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C1-C2 of almost 180, so that the distances of HS and HR
from NAD1-C4 were 4.8 A˚ and 5.6 A˚, respectively. The C2-
atom remained almost in the same position in the R1 pocket,
although the direction of the C1-C2 axis moved from R1(b)
to R1(a). This suggests that the dipole induced by the three
fluoroatoms at the C1 position of TFE is stabilized by the C7-
amide of NAD1, which makes up the floor of the R1(b) part
of the alcohol binding site. Such a stabilization of the polar
group of the substrate by the C7-amide of NAD1 is also
observed in the x-ray structure of the ternary ENADH
acetate complex, where one of the oxygen atoms in acetate
was localized in this part of the R1 pocket and the methyl
group was localized in the R2 pocket (12).
The vdW and electrostatic energies of the ligand with the
active site amino acids were calculated for the coordinate set
after 5 ns MDs. As expected, the amino acids in the R1
pocket gave more favorable vdW interactions than did those
in the R2 pocket. In DmADH, PYR exhibited more favorable
(10.76 vs. 3.02 kcal/mol) interactions than TFE, partly
due to the unfavorable hydrophobic contacts of Tyr-152 with
TFE. In contrast, active site amino acids in DlADH showed
similar magnitude (8.79 vs. 9.61 kcal/mol) of hydropho-
bic interactions to PYR and TFE.
The deprotonated Tyr-151 showed strong electrostatic in-
teraction with TFE, which overcame the unfavorable inter-
actions of Ser-138 and Lys-155. This strong interaction may
have contributed to the overestimation of the LIE values of
TFE. PYR interacted with Tyr-155 with electrostatic energies
of 14.1 and 7.9 kcal/mol in DmADH and DlADH,
respectively. For TFE, the corresponding electrostatic ener-
gies were 26.45 and 21.88 kcal/mol, respectively.
CONCLUSIONS
The overall 3D folding and the catalytic triad amino acids are
highly conserved within the family of SDRs. Therefore,
knowledge about the ionization of the catalytic triad of the
DADHs is helpful in the design of inhibitors for human SDRs.
The results of the calculations are summarized in Scheme 2.
The scenario giving the strongest ICM binding energy,
highest HINT score value (largest positive value), and a free
energy of binding (LIE values) closest to the experimental
results (Table 1) was considered the most probable scenario
when an inhibitor binds to the binary ENAD1 complexes
of SDRs. Scheme 2 indicates that scenario C (Ser-OH=
Tyr-O=Lys-NH13 ) is the most probable of the catalytic triad
of SDRs.
HINT scores showed clearly that Lys-155 should be in the
charged condition, which is supported by the electrostatic
surface analysis of the active site of binary and ternary com-
plexes of DADHs andMD-based binding energies. As shown
in Scheme 2, some of the calculations were in favor of
scenario B (Ser-OH/Tyr-O/Lys-NH2). However, deproto-
nation of both Lys-155 andTyr-151 at the catalytic site should
be considered highly unfavorable for the following reasons:
1), The positively charged Nz of Lys-155 can be appreciably
bonded (distance is;3 A˚) to both the O29 and the O39 atoms
ofNAD1-ribose,which is important for binding and orienting
the NAD1molecule at the active site (12). 2), The positively
charged Lys-155 also contributes to lowering the pKa of Tyr-
151 and Ser-138 in contrast to a neutral Lys. Hydrogen
bonding and trajectory analyses suggested that Ser-138
stabilized the ligand by dynamic hydrogen bonding with the
ligand. Based on the familiar conservation and structural
similarities, this network of interactions might be a general
trend among the SDRs.
During the MDs, the inhibitors changed their positions
within the active site. This was not surprising when we
consider the structure of the active site and the substrate
specificity of DADHs. These enzymes are most active with
secondary alcohols, where the active site cleft close to the C1
atom of an alcohol is quite wide. The movement of TFE
during the MDs suggested that the two polar parts of the
inhibitor are partly fixed. The CF3 group of TFE is locked by
the partly polar floor of the R1(b) site (the C7-amide of
NAD1), and the OH group is locked by the side chain oxygen
of Tyr-151. However, the methylene group of TFE was
moved significantly, so that the pro-R hydrogenmoved closer
to the C4 position of NAD1 from the starting structure.
Despite the movement of the methylene group of TFE, the
pro-S hydrogen was closest to the C4 position of NAD1.
Therefore TFE must be regarded as an appropriate model
for the binding of ethanol in the ternary complex and reflects
the stereochemistry of the reaction where the pro-S hydro-
gen is transferred from ethanol to NAD1 (80,81). The MDs
of the alcohol competitive inhibitor PYR with DlADH and
DmADH suggested that the plane of the ring favored the
perpendicular position relative to the si-face of the nicotin-
amide ring. Hence, orientation of PYR inside the binding
cavity is influenced by the positively charged C4 atom of
NAD1, the OH group of the Tyr-151 side chain, and, partly,
the OH group of the Ser-138 side chain. This is similar to the
binding of PYR to horse liver ADH, where the two nitrogen
atoms in PYR are oriented against the active site zinc atom
and the C4 atom of NAD1, whereas its perpendicular
position against the nicotinamide ring is stabilized by
stacking against Phe-93 (78,79). The MD simulations and
affinity calculations emphasize the importance of the charge
of the catalytic residues as well as the size and nature of the
active site topology close to the catalytic residues in the
development of inhibitors against SDR enzymes, where
small inhibitors might be more mobile in the active site than
larger inhibitors.
The overestimation of TFE affinities compared with ex-
perimental observations is explainable, and the affinity pre-
dictions for PYR and the MD simulations were in agreement
with experimental observations. Our calculations therefore
indicate that the DlADH and DmADH are valuable model
systems for studying the ionization conditions and inhibitor
binding of the SDR superfamily of enzymes using theoretical
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calculations. This study also confirms the fact that the use of
theoretical calculations for predicting and comparing binding
affinities of structurally different ligands is challenging.
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